{"id":"NCT04737187","sponsor":"Taiho Oncology, Inc.","briefTitle":"Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients","officialTitle":"An Open-label, Randomized, Phase III Study Comparing Trifluridine/Tipiracil in Combination With Bevacizumab to Trifluridine/Tipiracil Monotherapy in Patients With Refractory Metastatic Colorectal Cancer (SUNLIGHT Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-11-25","primaryCompletion":"2022-07-19","completion":"2023-09-12","firstPosted":"2021-02-03","resultsPosted":"2023-12-26","lastUpdate":"2024-09-24"},"enrollment":492,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Refractory Metastatic Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"Trifluridine/Tipiracil","otherNames":["TAS102","S 95005","Lonsurf"]},{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin"]}],"arms":[{"label":"Trifluridine/Tipiracil + Bevacizumab","type":"EXPERIMENTAL"},{"label":"Trifluridine/Tipiracil","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed as an international, open-label, controlled two-arm, randomized phase III comparison study evaluating the efficacy and safety of trifluridine/tipiracil in combination with bevacizumab versus trifluridine/tipiracil monotherapy in patients with refractory mCRC.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization to the death due to any cause or cut-off date, whichever comes first (maximum duration: up to 20 months)","effectByArm":[{"arm":"Trifluridine/Tipiracil + Bevacizumab","deltaMin":10.78,"sd":null},{"arm":"Trifluridine/Tipiracil","deltaMin":7.46,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":99,"countries":["United States","Austria","Belgium","Brazil","Denmark","France","Germany","Hungary","Italy","Poland","Puerto Rico","Russia","Spain","Ukraine"]},"refs":{"pmids":["37133585","38953855"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":246},"commonTop":["Neutropenia","Nausea","Anaemia","Asthenia","Diarrhoea"]}}